These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7863014)

  • 81. CCK-4: Psychophysiological conditioning elicits features of spontaneous panic attacks.
    Hinkelmann K; Yassouridis A; Mass R; Tenge H; Kellner M; Jahn H; Wiedemann K; Wolf K
    J Psychiatr Res; 2010 Dec; 44(16):1148-53. PubMed ID: 20451215
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Centrally administered cholecystokinin suppresses feeding through a peripheral-type receptor mechanism.
    Crawley JN; Fiske SM; Durieux C; Derrien M; Roques BP
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1076-80. PubMed ID: 2046021
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Estrogen modulation of opioid and cholecystokinin systems in the limbic-hypothalamic circuit.
    Micevych PE; Eckersell CB; Brecha N; Holland KL
    Brain Res Bull; 1997; 44(4):335-43. PubMed ID: 9370197
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Cholecystokinin-A but not cholecystokinin-B receptor stimulation induces endogenous opioid-dependent antinociceptive effects in the hot plate test in mice.
    Derrien M; Noble F; Maldonado R; Roques BP
    Neurosci Lett; 1993 Oct; 160(2):193-6. PubMed ID: 8247353
    [TBL] [Abstract][Full Text] [Related]  

  • 85. HPA axis activity in patients with panic disorder: review and synthesis of four studies.
    Abelson JL; Khan S; Liberzon I; Young EA
    Depress Anxiety; 2007; 24(1):66-76. PubMed ID: 16845643
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Role of cholecystokinin in appetite control and body weight regulation.
    Little TJ; Horowitz M; Feinle-Bisset C
    Obes Rev; 2005 Nov; 6(4):297-306. PubMed ID: 16246215
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Effect of central and peripheral administrations of cholecystokinin-tetrapeptide on panic-like reactions induced by stimulation of the dorsal periaqueductal grey area in the rat.
    Mongeau R; Marsden CA
    Biol Psychiatry; 1997 Sep; 42(5):335-44. PubMed ID: 9276073
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Cholecystokinin inhibits gastric acid secretion through type "A" cholecystokinin receptors and somatostatin in rats.
    Lloyd KC; Raybould HE; Walsh JH
    Am J Physiol; 1992 Sep; 263(3 Pt 1):G287-92. PubMed ID: 1357976
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Cholecystokinin (CCK) regulates somatostatin secretion through both the CCK-A and CCK-B/gastrin receptors in sheep.
    Zavros Y; Shulkes A
    J Physiol; 1997 Dec; 505 ( Pt 3)(Pt 3):811-21. PubMed ID: 9457654
    [TBL] [Abstract][Full Text] [Related]  

  • 90. A dose-ranging study of the behavioral and cardiovascular effects of CCK-tetrapeptide in panic disorder.
    Bradwejn J; Koszycki D; Annable L; Couëtoux du Tertre A; Reines S; Karkanias C
    Biol Psychiatry; 1992 Nov; 32(10):903-12. PubMed ID: 1467375
    [TBL] [Abstract][Full Text] [Related]  

  • 91. From gut nutrient sensing to nutrient perception: a cooperative role involving CCK and 5-HT?
    Tomé D
    Am J Physiol Regul Integr Comp Physiol; 2007 Mar; 292(3):R1061-2. PubMed ID: 17158260
    [No Abstract]   [Full Text] [Related]  

  • 92. Cholecystokinin in anxiety.
    van Megen HJ; Westenberg HG; den Boer JA; Kahn RS
    Eur Neuropsychopharmacol; 1996 Nov; 6(4):263-80. PubMed ID: 8985709
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Association between the CCK-A receptor gene and panic disorder.
    Ise K; Akiyoshi J; Horinouchi Y; Tsutsumi T; Isogawa K; Nagayama H
    Am J Med Genet B Neuropsychiatr Genet; 2003 Apr; 118B(1):29-31. PubMed ID: 12627462
    [TBL] [Abstract][Full Text] [Related]  

  • 94. CCK in animal and human research on anxiety.
    Harro J; Vasar E; Bradwejn J
    Trends Pharmacol Sci; 1993 Jun; 14(6):244-9. PubMed ID: 8372405
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Cholecystokinin in the central nervous system: a minireview.
    Beinfeld MC
    Neuropeptides; 1983 Oct; 3(6):411-27. PubMed ID: 6141537
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Neuroactive steroids are not affected by panic induction with 50 microg cholecystokinin-tetrapeptide (CCK-4) in healthy volunteers.
    Zwanzger P; Eser D; Padberg F; Baghai TC; Schüle C; Rupprecht R; di Michele F; Romeo E; Pasini A; Ströhle A
    J Psychiatr Res; 2004; 38(2):215-7. PubMed ID: 14757337
    [No Abstract]   [Full Text] [Related]  

  • 97. On the role of cholecystokinin in pancreatic cancer.
    Herrington MK; Adrian TE
    Int J Pancreatol; 1995 Apr; 17(2):121-38. PubMed ID: 7622936
    [No Abstract]   [Full Text] [Related]  

  • 98. Challenge studies in anxiety disorders.
    Keck ME; Ströhle A
    Handb Exp Pharmacol; 2005; (169):449-68. PubMed ID: 16594268
    [TBL] [Abstract][Full Text] [Related]  

  • 99. CCK hypothesis: proof and problems.
    Smith GP
    Appetite; 1991 Aug; 17(1):76. PubMed ID: 1952922
    [No Abstract]   [Full Text] [Related]  

  • 100. Acute effects of low-dose flumazenil in panic disorder.
    Maddock RJ
    J Clin Psychopharmacol; 1998 Jun; 18(3):258-61. PubMed ID: 9617991
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.